Long known to be associated with the risk of serious adverse events, proton pump inhibitors (PPIs) have now been shown to increase the risk of all cause mortality, and specifically deaths due to cardiovascular disease and chronic kidney disease. The findings reinforce messages to consumers and clinicians that the drugs should only be used when medically ...
More evidence & warnings on PPI use
By Mardi Chapman
6 Jun 2019